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The authors regret to inform readers that the chemical structure presented in figure 1 is 
incorrect. The correct chemical structure for Ag8 is presented below.  The authors would like 
to apologise for any inconvenience caused. 
 
 
 
 
  
 
 
 
  
 
Fig 1. Chemical Structure of Ag8 
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